[Federal Register Volume 77, Number 218 (Friday, November 9, 2012)]
[Notices]
[Pages 67398-67399]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-27400]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application; INB 
Hauser Pharmaceutical Services, Inc.

    Pursuant to Sec.  1301.33(a), Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on September 20, 2012, InB 
Hauser Pharmaceutical Services, Inc., 6880 N. Broadway, Suite H, 
Denver, Colorado 80221, made application by letter to the Drug 
Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of 4-Anilino-N-phenethyl-4-piperidine (8333), a basic 
class of controlled substance listed in schedule II.
    The company plans to manufacture the listed controlled substance in 
bulk for distribution and sale to its customers.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substance, may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such written comments or objections should be addressed, in

[[Page 67399]]

quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than January 8, 2013.

    Dated: November 1, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2012-27400 Filed 11-8-12; 8:45 am]
BILLING CODE 4410-09-P